Low dose iron supplement
Pro Research Analysisby 
Searched over 200M research papers
Low Dose Iron Supplementation: Efficacy and Safety
Introduction to Low Dose Iron Supplementation
Iron deficiency is a common health issue, particularly among premenopausal women, children, and pregnant women. While high-dose iron supplements are often prescribed, they can cause gastrointestinal side effects. Recent research has focused on the efficacy and safety of low-dose iron supplementation as a potential alternative.
Efficacy of Low Dose Iron Supplementation in Women
Premenopausal Women
Studies have shown that low-dose iron supplementation can effectively improve iron status in premenopausal women with iron deficiency without anemia (IDWA). For instance, a study involving 85 premenopausal women found that a low-dose liquid iron supplement (27 mg) significantly increased serum ferritin and total serum iron levels without causing gastrointestinal distress4. Another study demonstrated that a daily dose of 27 mg iron increased serum ferritin levels significantly within one month and maintained these levels over six months1. However, a lower dose of 9 mg did not significantly affect iron stores1.
Pregnant Women
In pregnant women, low-dose iron supplementation has been shown to prevent iron deficiency anemia (IDA) effectively. A randomized controlled trial with 430 pregnant women revealed that a daily dose of 20 mg iron from the 20th week of gestation until delivery significantly reduced the prevalence of IDA and iron deficiency without causing gastrointestinal side effects7. Another study comparing different doses (20 mg, 40 mg, and 80 mg) found that while higher doses were more effective in increasing hemoglobin levels, the 20 mg dose was associated with fewer gastrointestinal side effects10.
Efficacy in Children
Preschool Children
In children, low-dose iron supplementation has shown mixed results. A study conducted in Zanzibar with preschool children found that while low-dose iron (10 mg daily) improved serum ferritin and erythrocyte protoporphyrin levels, it did not significantly affect hemoglobin concentration or anemia2. However, the same study noted that iron supplementation improved appetite, as reported by mothers2.
Infants
For infants, low-dose iron supplementation has been beneficial in improving iron status without adverse effects on growth or illness. A study in rural China found that iron supplementation from 6 weeks to 9 months of age modestly increased infant iron status at 9 months without decreasing growth or increasing illness9. Similarly, a study on marginally low birth weight infants showed that iron supplementation at 2 mg/kg per day significantly reduced the risk of iron deficiency anemia without affecting growth or morbidity8.
Safety of Low Dose Iron Supplementation
Gastrointestinal Side Effects
One of the primary concerns with iron supplementation is gastrointestinal side effects. Research indicates that low-dose iron supplements are generally well-tolerated. For example, a study on premenopausal women found no significant increase in gastrointestinal distress with a 27 mg daily dose4. In pregnant women, a 20 mg daily dose was associated with fewer gastrointestinal side effects compared to higher doses10.
Malaria Risk
In malaria-endemic regions, there is concern that iron supplementation might increase the risk of malaria. However, a study in Zanzibar found that low-dose iron supplementation for 12 months did not increase the prevalence or density of malaria infection in young children6.
Conclusion
Low-dose iron supplementation appears to be an effective and safer alternative to high-dose supplements for improving iron status in various populations, including premenopausal women, pregnant women, and children. It effectively increases serum ferritin and iron levels while minimizing gastrointestinal side effects. However, its impact on anemia varies, and further research is needed to optimize dosing strategies for different populations.
Sources and full results
Most relevant research papers on this topic
Effects of low-dose iron supplementation in women with low serum ferritin concentration.
Low-dose iron supplementation with 27 mg daily effectively corrects mild anemia and storage iron depletion in premenopausal women, while 9 mg dose does not affect iron stores.
RCTLow dose daily iron supplementation improves iron status and appetite but not anemia, whereas quarterly anthelminthic treatment improves growth, appetite and anemia in Zanzibari preschool children.
Low dose daily iron supplementation improves iron status and appetite, but not anemia, while quarterly anthelminthic treatment improves growth, appetite, and anemia in Zanzibari preschool children.
RCT
Highly CitedBioavailability of daily low dose iron supplements in menstruating women with low iron stores.
Low-dose iron supplements can improve iron status in menstruating women with low iron stores without causing iron intolerance.
RCTAssessment of the Efficacy of a Low-Dose Iron Supplement in Restoring Iron Levels to Normal Range among Healthy Premenopausal Women with Iron Deficiency without Anemia
A low-dose iron supplement improves blood-iron levels in premenopausal women with iron deficiency without anemia without causing significant gastrointestinal distress.
RCTRandomized Trial Comparing Proactive, High-Dose versus Reactive, Low-Dose Intravenous Iron Supplementation in Hemodialysis (PIVOTAL): Study Design and Baseline Data
Proactive, high-dose intravenous iron supplementation is noninferior to reactive, low-dose iron supplementation in preventing nonfatal heart attacks, strokes, and heart failure in hemodialysis patients.
RCT
Large Human TrialLow-dose daily iron supplementation for 12 months does not increase the prevalence of malarial infection or density of parasites in young Zanzibari children.
Low-dose daily iron supplementation for 12 months in young Zanzibari children does not increase the prevalence of malaria infection or parasite density in this high malaria transmission environment.
RCTLarge Human TrialEfficacy and tolerability of low-dose iron supplements during pregnancy: a randomized controlled trial.
Low-dose iron supplements (20 mg/d) during pregnancy effectively prevent iron deficiency and anemia without causing gastrointestinal side effects.
RCTLarge Human TrialHighly CitedIron Supplements Reduce the Risk of Iron Deficiency Anemia in Marginally Low Birth Weight Infants
Iron supplementation at 2 mg/kg per day from 6 weeks to 6 months effectively reduces the risk of iron deficiency and anemia in marginally low birth weight infants without short-term adverse effects on morbidity or growth.
RCTHighly CitedLow-Dose Iron Supplementation in Infancy Modestly Increases Infant Iron Status at 9 Mo without Decreasing Growth or Increasing Illness in a Randomized Clinical Trial in Rural China.
Low-dose iron supplementation in infancy reduces iron deficiency at 9 months without adverse effects on growth or illness in Chinese infants.
RCTLarge Human Trial
Very Rigorous JournalShould we lower the dose of iron when treating anaemia in pregnancy? A randomized dose–response trial
Low-dose iron supplements may be effective in treating anaemia in pregnancy with less gastrointestinal side effects compared to high-dose supplements.
RCTHighly Cited